Springer Nature, London, 2025.
Viral hepatitis is a major public health challenge and the WHO has set an elimination target for 2030. This article notes the opportunities presented by vaccines and new drugs, reviews global progress and sets out recommendations for high burden countries to achieve elimination.
Taskforce for Global Health, Decatur GA, 2025. 1p.
Summarises "2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles".
Taskforce for Global Health, Decatur GA, 2025. 1p.
Summarises "2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles".
Elsevier, London, 2025. 16p.
Reviews the status of national data, policy, and programme development for the elimination of viral hepatitis.
Elsevier, London, 2025. 16p.
Reviews the status of national data, policy, and programme development for the elimination of viral hepatitis.
Coalition for Global Hepatitis Elimination, Decatur GA, 2025. 21p.
Summarises the status of hepatitis B and C elimination, bringing together data on the burden of hepatitis, key interventions and policy development.
European Association for the Study of the Liver (EASL), Geneva, 2023. 5p.
Hepatitis D virus (HDV) infection occurs as a coinfection with hepatitis B and increases the risk of hepatocellular carcinoma, decompensated cirrhosis, and mortality compared to hepatitis B virus (HBV) monoinfection. Reliable estimates of the prevalence of HDV infection and disease burden are essential to formulate strategies to find coinfected individuals more effectively and efficiently.
Coalition for Global Hepatitis Elimination, Decatur GA, 2025. 1p.
A global laboratory survey was undertaken by the Coalition for Global Hepatitis Elimination and the University of North Carolina in collaboration with WHO to investigate the scope, use, and implementation experience of reflex viral load for HBV DNA and also reflex HDV serology and HDV RNA testing.
World Hepatitis Alliance, Geneva, 2025. 17p.
Despite affecting 12 million people globally, data on hepatitis delta is poor, awareness is extremely low and access to screening and treatment is out of reach for most.
World Hepatitis Alliance, Geneva, 2025. 12p.
The first ever World Hepatitis Testing Week highlighted the urgent need to increase diagnosis globally if we are to come close to meeting any of the 2030 hepatitis elimination goals.
Elsevier, London, 2025. 13p.
The age of people who inject drugs appears to be increasing in some high-income countries. We aimed to explore trends in the age of people injecting and recently starting to inject drugs in Australia, and to model incidence of initiation over time.
MDPI, Basel, 2025. 18p.
The treatment landscape for hepatitis C virus (HCV) infection has transformed over the past few decades, evolving from the limited efficacy of interferon (IFN) monotherapy to the highly successful pan-genotypic direct-acting antivirals (DAAs) used today.
European Association for the Study of the Liver (EASL), Geneva, 2025. 82p.
Presents updated recommendations for the optimal management of HBV infection.
World Health Organization, Geneva, 2025. 82p.
This guideline provides evidence-informed guidance on the use of lower-sodium salt substitutes.
LiverHealthPOD, Melbourne, 2025. Podcast.
John, Paul and Will are three Liver Doctors (Hepatologist). In this series, they discuss all aspects of keeping you liver healthy and understanding common conditions that effect the liver.
The Conversation, Melbourne, Sydney, 2025.
Australia leads the world in community-based needle programs. Yet they’re not used in prisons which are hotspots for hepatitis C infection.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.